2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
84
Prostatic Neoplasms
73
Leukemia, Myeloid, Acute
73
Carcinoma, Non-Small-Cell Lung
61
Neoplasm Metastasis
60
Breast Neoplasms
56
Multiple Myeloma
47
Colorectal Neoplasms
47
Pancreatic Neoplasms
43
Melanoma
36
Carcinoma, Renal Cell
36
Myelodysplastic Syndromes
35
Ovarian Neoplasms
33
Leukemia, Lymphocytic, Chronic, B-Cell
30
Triple Negative Breast Neoplasms
28
Glioblastoma
28
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma, Large B-Cell, Diffuse
26
Urinary Bladder Neoplasms
25
Lymphoma
23
Squamous Cell Carcinoma of Head and Neck
22
Burkitt Lymphoma
22
Fallopian Tube Neoplasms
21
Glioma
20
Carcinoma, Hepatocellular
20
Brain Neoplasms
18
Mouth Neoplasms
17
Lymphoma, Non-Hodgkin
17
Leukemia, Biphenotypic, Acute
17
Endometrial Neoplasms
17
Interventions
Melphalan
3
Blood Specimen Collection
3
Magnetic Resonance Spectroscopy
2
thymoglobulin
1
sargramostim
1
romidepsin
1
montanide ISA 51
1
keyhole-limpet hemocyanin
1
ixazomib
1
detox adjuvant
1
Waiting Lists
1
Ursodeoxycholic Acid
1
Transplantation
1
Thalidomide
1
Tablets
1
Surveys and Questionnaires
1
Streptozocin
1
Specimen Handling
1
Restraint, Physical
1
Radiosurgery
1
Radiation
1
Mercaptopurine
1
Leucovorin
1
Ketoconazole
1
Interleukin-2
1
Fulvestrant
1
Floxuridine
1
FANG vaccine
1
Docetaxel
1
Diagnostic Tests, Routine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Genetic Diseases, Inborn
×
Specimen Handling
×
Clear all
NCT05587439
2025-07-10
INHERIT
Dana-Farber Cancer Institute
Recruiting
500 enrolled